Syngene International Ltd.

₹638.9

Syngene International Ltd.

₹638.9

₹638.9

-3.75 (-0.58%) - 30 Jun 2025 04:26 PM

About Company

Syngene International Limited, incorporated in 1993, is an internationally reputed contract research and manufacturing organization, which supports R&D programs from lead generation to clinical supplies. The company’s multi-disciplinary skills in integrated drug discovery and development include capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services. The company has state-of-the-art research facilities certified with ISO 9001:2008, ISO 14001:2004, and OHSAS 18001:2007. The company’s animal facilities are GLP certified by the Indian authorities and AAALAC accredited.

Market Cap. ₹ 25,744 Cr.
52 Week - High/Low ₹ 961/600
P/E Ratio 55.26
P/B Ratio 6.18
Enterprise Value ₹ 26,101 Cr.
ROE % 10.65
RSI Value 41.64
EMA 50 655.66
EMA 200 723.84
Market Cap. ₹ 25,744 Cr.
52 Week - High/Low ₹ 961/600
P/E Ratio 52.12
P/B Ratio 6.08
Enterprise Value ₹ 26,201 Cr.
ROE % 13.18
RSI Value 41.64
EMA 50 655.66
EMA 200 723.84

Growth

Valuation

Calculators

Peer Comparison

Industry - Business Support

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.